Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
Both proteins are fundamental for an optimal surfactant activity in vivo and SP-B genetic deficiency causes lethal respiratory failure after birth.
|
30075031 |
2018 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
Although rare, childhood ILD (chILD) is associated with significant morbidity and mortality, most notably in conditions of disordered surfactant function, with respiratory failure in 100% of neonates with surfactant protein B dysfunction and 100% mortality without lung transplantation.
|
29019755 |
2017 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
All SFTPB cases died from intractable respiratory failure.
|
23625987 |
2013 |
Respiratory Failure
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
To characterize inheritance of homozygous, rare, recessive loss-of-function mutations in surfactant protein-B (SFTPB) or ATP binding cassette, subfamily A, member 3 (ABCA3) genes in newborns with lethal respiratory failure.
|
19647838 |
2009 |
Respiratory Failure
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Recessive loss of function mutations in surfactant protein-B (SP-B) gene lead to respiratory failure that is lethal in the newborn period while single allelic mutations in the surfactant protein-C (SP-C) gene cause interstitial lung disease of varying severity and age of onset.
|
17142157 |
2006 |
Respiratory Failure
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
The objective was to determine whether the SP-B + 1580 CC genotype is associated with an increased risk of respiratory failure and ARDS in adults with community-acquired pneumonia.
|
15190959 |
2004 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
Rare mutations causing an absence of the SP-B protein result in progressive respiratory failure.
|
12667827 |
2003 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
Hereditary SP-B deficiency is a rare, newly diagnosable and probably under-recognized disease, which should be suspected in term newborn infants with unexplained respiratory failure.
|
10663288 |
2000 |
Respiratory Failure
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Homozygosity for a common mutation (1549C-->GAA, or 121ins2) of the SP-B-encoding gene (SFTPB) results in rapidly fatal respiratory failure, with complete absence of the mRNA and protein observed in lung fluid or biopsy specimens.
|
10571948 |
1999 |
Respiratory Failure
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Inherited deficiency of surfactant protein-B (SP-B) is a fatal autosomal recessive disorder of lung cell metabolism caused most frequently by a frameshift mutation in codon 121 of the SP-B gene (121ins2) and is characterized by rapidly progressive respiratory failure immediately after birth.
|
9927351 |
1999 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
We conclude that this patient had a transient deficiency of SP-B, in contrast to that of previously described infants with irreversible respiratory failure caused by hereditary SP-B deficiency.
|
9506635 |
1998 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
Ablation of the SP-B gene disrupts the routing, storage, and function of surfactant phospholipids and proteins, causing respiratory failure at birth.
|
7644495 |
1995 |
Respiratory Failure
|
0.200 |
GeneticVariation
|
disease |
BEFREE |
Congenital alveolar proteinosis (CAP) is an often fatal cause of respiratory failure in term newborn infants, which has been associated with a genetic deficiency of surfactant protein B (SP-B) as a result of a frameshift mutation (121ins2) in a family with three affected siblings.
|
8021783 |
1994 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
BEFREE |
To determine the molecular defect accounting for the deficiency of pulmonary surfactant protein B (SP-B) in full-term neonates who died from respiratory failure associated with alveolar proteinosis, the sequence of the SP-B transcript in affected infants was ascertained.
|
8163685 |
1994 |
Respiratory Failure
|
0.200 |
Biomarker
|
disease |
HPO |
|
|
|